TMEM119 and Parkinson disease: Post hoc analyses demonstrated a significant increase in the nigral TMEM119-immunofluorescent area in subjects with MMD-LB (p < 0.001), PD (p < 0.001), and PSP (p < 0.001) compared with the control group.